Elisabeth Jappay
Internal Medicine · Salem, ORNPI 1538214036
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,422 and has fallen 95.0% since, to $71 in 2022. Among internal medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 213 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$643
- Johnson & Johnson$580
- Kowa Pharmaceuticals America, Inc.$346
- AstraZeneca$328
- AbbVie$273
- Pfizer$184
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,673100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 31 | $643 |
| Johnson & Johnson(2 entities) | 35 | $580 |
| Kowa Pharmaceuticals America, Inc. | 16 | $346 |
| AstraZeneca | 19 | $328 |
| AbbVie(2 entities) | 24 | $273 |
| Pfizer | 14 | $184 |
| Novo Nordisk | 11 | $177 |
| Teva Pharmaceuticals USA, Inc. | 4 | $168 |
| Lilly USA, LLC | 7 | $117 |
| Sanofi-aventis U.S. LLC | 7 | $109 |
| Medtronic(2 entities) | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $99 |
| Amarin Pharma, Inc. | 5 | $99 |
| Merck | 6 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $65 |
| Sunovion Pharmaceuticals Inc. | 3 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $46 |
| GSK | 3 | $43 |
| Boehringer Ingelheim | 2 | $30 |
| Novartis | 2 | $25 |
| Alfasigma USA, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Philips North America LLC | 1 | $11 |
| Corcept Therapeutics | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AJOVY$138
How this compares
$3,686 in reported general payments places this provider in the 95th percentile of 1,363 internal medicine providers in Oregon.
Other internal medicine in Salem
- Chad PfeferBeaverton$639K
- Pranav ChandrashekarPortland$81K
- Jonathan EdmistonBend$68K
- Jessica CastlePortland$66K
- Ellen Schiaffino PurvisGresham$66K
- Steven ShawWhite City$58K
- Stephen SpurgeonPortland$42K
- Jane BabiarzPortland$30K
- Andrew HarbisonPortland$29K
- Marc UemuraEugene$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.